Cosmo Pharmaceuticals N.V. (0RGI.L) LSE

65.77

+0.57455(+0.88%)

Updated at September 05 05:24PM

Currency In CHF

Valuation

Market Cap1.11B
Enterprise Value1.07B
P/E Ratio8.62
PEG Ratio0.1
Price/Sales Ratio4.19
Price/Book Ratio2.3
Enterprise/Revenue4.03
Enterprise/EBITDA6.5

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin0.5
Operating Margin0.56

Management Effectiveness

Return On Assets0.21
Return On Equity0.27

Income Statement

Revenue266.79M
Revenue/Share16.31
Gross Profit246.92M
EBITDA165.71M
Net Income133.24M
Diluted EPS8.12

Balance Sheet

Total Cash142.96M
Total Cash/Share8.74
Total Debt2.2M
Total Debt/Equity0
Current Ratio4.19
Book Value Per Share30.88

Price History

52-Week Change-16.74
52-Week High68.6
52-Week Low33.75
Moving Average 50 Days63.2
Moving Average 200 Days48.12

Statistics

Average Volume1,442
Shares Outstanding15.94M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.92
Trailing Annual Dividend Yield2.73
Payout Ratio0.24
Last Split FactorN/A
Last Split DateN/A